Blood Irradiation Market

Global Blood Irradiation Market Size (2024 to 2029)

The global blood irradiation market size is estimated to be growing at a CAGR of 5.49% from 2024 to 2029 and worth USD 90.47 million by 2029 from USD 69.25 million in 2024.

Blood irradiation is a treatment that involves irradiating blood components before transfusion to prevent the proliferation of types of T cells. These T lymphocytes suppress immunological responses, resulting in rare graft-versus-host disease (GVHD) with severe white blood cell transfusion complications. A gamma irradiation chamber with a blood irradiator is one example of this type of gamma irradiation chamber. The use of gamma rays to irradiate blood and blood products has been shown to reduce the incidence of post-transfusion graft versus host disease. According to a study, gamma irradiation of cellular blood components is the best current approach for reducing recipient T-GVHD risk. According to the American Association of Blood Banks (AABB), the cellular blood components are irradiated before transfusion to inhibit the development of viable T lymphocytes, which are the primary source of transfusion-associated infections. Blood is commonly irradiated with a cobalt-60 or cesium-137 radioactive source in normal blood bags in specialized blood irradiators. Blood products are irradiated using a specialized blood irradiator with a long half-life gamma-emitting source located on-site. The outcomes of irradiation of blood products take about 4-5 minutes to appear.

MARKET DRIVERS

The growth of the global blood irradiation market is majorly driven by the global population becoming more vulnerable to different communicable and non-communicable diseases (NCDs), such as cancer, chronic renal disease, high blood pressure disease, stroke, and cardiovascular disorders.

The risk has been considerably lowered because of the usage of X-ray irradiators. UV blood irradiation (UVBI) by UV lamps is accomplished using this technology. The radiation is delivered via the skin using the transcutaneous approach, which involves inserting a device outside the skin. A device is placed into a significant blood artery in the intravenous approach. X-ray irradiators have improved the safety of our blood supply and the security of our facilities. The use of an X-ray irradiator has also increased reliability and performance. A rising number of cases involving a blood transfusion problem and the increasing prevalence of lifestyle-related disorders are two key factors driving the growth in the global market. Furthermore, developing new medical technologies, increased healthcare expenditure and government initiatives propel the global blood irradiator market forward.

During the forecast period, the global blood irradiation market is expected to rise due to the number of patients suffering from diseases and technological improvements in the medical device industry. Furthermore, improving health outcomes in medical devices is expected to provide significant market growth opportunities. Laser irradiation therapies are used to diagnose and treat infections in the bloodstream. Manufacturers are developing revolutionary blood irradiation systems for enhanced health treatments as such therapies grow, directly driving the market growth.

MARKET RESTRAINTS

The lack of competent experts in emerging economies and regulatory laws governing medical systems is anticipated to restrict the expansion of the global blood irradiation market. Transfusion delay, cost, failure to irradiate when needed, increased potassium accumulation in and lower shelf life of RBC units, and reduced RBC recovery are all problems and challenges connected with blood component irradiation.

Impact of COVID-19 on the global blood irradiation market

The SARS-CoV-2-caused coronavirus disease-2019 (COVID-19) epidemic has significantly affected healthcare systems worldwide. In most patients, the cytokine storm that follows lung infection is causally connected to respiratory impairment and mortality. To combat the spread of Covid-19, governments worldwide imposed lockdowns and restrictions. This significantly impacted global value chains and skills for dissemination and coordination. In addition, several end-client companies have lost a large amount of money due to their falling popularity. Vaccination will go a long way toward containing and managing global pandemics.

The development of various viral diseases, ranging from HIV/AIDS to Ebola, SARS, MERS, and SARS-CoV-2, has brought this therapeutic opportunity back to the forefront. BI (blood irradiation) has a multifaceted virucidal effect, primarily affecting the immune system. Extracorporeal photopheresis (ECP), a more technical procedure, also treats hematological tumors such as T-cell lymphomas. More research into BI could lead to the development of a practical device that could combat novel viruses resistant to known antivirals or vaccines and bacteria resistant to known antibiotics. As a result, the market has had moderate growth during this pandemic.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Blood Irradiation Market Analysis By Type

Over the next few years, the gamma-ray blood irradiation segment will have the largest share of the global blood irradiation market. This is mainly due to many benefits, including quickly irradiating blood samples, platelets, and loaded syringes. Furthermore, gamma irradiation is the most used sterilizing procedure.

Global Blood Irradiation Market Analysis By Application

The hospital segment is expected to control most of the market during the forecast period. This is mainly owing to an increase in traumatic injury cases around the world.

REGIONAL ANALYSIS

North America is expected to account for the largest share of the worldwide blood irradiator devices market during the forecast period. The market in the region is predicted to grow substantially in the coming years, owing to an increase in the prevalence of disorders connected with blood transfusion and various government programs for developing new irradiators. Europe is predicted to be the second-largest market throughout the forecast period.

In the global blood irradiation market, Asia Pacific is predicted to develop faster than Europe. The blood irradiation market in the region is expected to develop as the region's population becomes more vulnerable to chronic diseases and the government becomes more involved in maintaining safety standards for new product launches.

KEY PLAYERS IN THE BLOOD IRRADIATION MARKET

Wuhan HNC Technology Co., Ltd., Wenzhou Gengsheng Health Medical Equipment Co., Ltd., O3Vets, Best Theratronics, Hitachi, Gilardoni, Gamma-Service, Cegelec, Shinva Medical, NPIC, and CIF medical are a few of the leading companies in the global blood irradiation market.

RECENT HAPPENINGS IN THIS MARKET

• JW Bioscience Co., Ltd., a South Korean medical device business, unveiled 'Sangray,' a blood radiation device, in November 2018.
• In September 2017, Typenex Medical LLC, a medical device company based in the US, unveiled Rad-Control – irradiation indication tag technology for blood banks and blood centers in the US and Canada.

DETAILED SEGMENTATION OF THE GLOBAL BLOOD IRRADIATION MARKET INCLUDED IN THIS REPORT

This research report on the global blood irradiation market has been segmented and sub-segmented based on type, application & region.

By Type

• Х-Rау
• Gаmmа-Rау

By Application

• Blood Bank
• Hospital
• Research Institutions

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa